Cyclosporin in atopic dermatitis. Review of the literature and outline of a Belgian consensus

Dermatology

Volumn 198, Issue 2, 1999, Pages 145-152

  Naeyaert, Jean Marie ^a   Lachapelle, J M ^b   Degreef, H ^b   De La Brassinne, M ^b   Heenen, M ^b   Lambert, J ^b  

^a GHENT UNIVERSITY HOSPITAL   (Belgium)

^b NONE

Author keywords

Atopic dermatitis; Consensus report; Cyclosporin

Indexed keywords

ALLOPURINOL; AMIODARONE; AZATHIOPRINE; CARBAMAZEPINE; CYCLOSPORIN; DANAZOL; DICLOFENAC; DILTIAZEM; ERYTHROMYCIN; FLUCLOXACILLIN; FLUCONAZOLE; GAMMA INTERFERON; GENTAMICIN; HISTAMINE H1 RECEPTOR ANTAGONIST; KETOCONAZOLE; MACROLIDE; METHYLPREDNISOLONE; METOCLOPRAMIDE; NAPROXEN; NICARDIPINE; OCTREOTIDE; PHENYTOIN; PRIMROSE OIL; RIFAMPICIN; STEROID; SULINDAC; THYMOPENTIN; TOBRAMYCIN; UNINDEXED DRUG; VERAPAMIL;

ARTICLE; ATOPIC DERMATITIS; CLINICAL TRIAL; DERMATOLOGY; DRUG CONTRAINDICATION; DRUG EFFICACY; HUMAN; LONG TERM CARE; META ANALYSIS; PHOTOCHEMOTHERAPY; PHOTOTHERAPY; PRACTICE GUIDELINE; PRIORITY JOURNAL; TOPICAL DRUG ADMINISTRATION;

CYCLOSPORINE; DERMATITIS, ATOPIC; HUMANS; IMMUNOSUPPRESSIVE AGENTS;

EID: 0032962426     PISSN: 10188665     EISSN: None     Source Type: Journal    
DOI: 10.1159/000018091     Document Type: Article

References (33)

1. Graham-Brown RAC: Therapeutics in atopic dermatitis; in James WD, Cockerell CJ, Dzubow LM, Paller AS, Yancey KB (eds): Advances in Dermatology. St Louis, Mosby, 1997, vol 13, pp 3-31.
2. Hanifin JM, Rajka G: Diagnostic features of atopic dermatitis. Acta Derm Venereol Suppl (Stockh) 1980;92:44-47.
3. Williams HC, Burney PGJ, Pembroke AC, Hay RJ: The UK Working Party's diagnostic criteria for atopic dermatitis. III. Independent hospital validation. Br J Dermatol 1994;131:406-416.
4. Holden CA, Parish WE: Atopic dermatitis; in Champion RH, Burton JL, Burns DA, Breathnach SM (eds): Textbook of Dermatology, ed 6. Oxford, Blackwell Science, 1998, pp 681-708.
5. Pryzbilla B, Eberlein-Konig B, Rueff F: Practical management of atopic eczema. Lancet 1994;343:1342-1346.
6. Long CC, Finlay AY: The finger tip unit - A new practical measure. Clin Exp Dermatol 1991;16:444-447.
7. Healsmith M, Berth-Jones J, Graham-Brown RAC: Histamine, antihistamines and atopic dermatitis. J Dermatol Treat 1991;1:325-330.
8. Klein P, Greene WH, Fuhrer J, Clark RAF: Prevalence of methicillin-resistant Staphylococcus aureus in outpatients with psoriasis, atopic dermatitis, or HIV infection. Arch Dermatol 1997;133:1463-1465.
9. Jekler J, Larko O: Phototherapy for atopic dermatitis with ultraviolet A (UVA), low dose UVB, and combined UVA and UVB: Two paired comparison studies. Photodermatol Photoimmunol Photomed 1991;8:151-156.
10. Bilsland D, Diffy BL, Dawe R, Farr P, Ferguson J, George S, Gibbz NK, Green C, McGregor J, Van Weelden H, Wainwright NJ, Young AR: An appraisal of narrowband (TL-01) UVB phototherapy. British Photodermatology Group Workshop Report (April 1996). Br J Dermatol 1997;137:327-330.
11. Sheehan M, Atherton DJ: A controlled trial of traditional Chinese medicinal plants in widespread non-exudative atopic eczema. Br J Dermatol 1992;126:179-184.
12. Graham-Brown R: Toxicity of Chinese herbal remedies. Lancet 1992;340:673.
13. European Task Force on Atopic Dermatitis: Severity scoring of atopic dermatitis: The SCO-RAD Index. Dermatology 1993;186:23-31.
14. Berth-Jones J: Six area, six sign atopic dermatitis (SASSAD) severity score: A simple system for monitoring disease activity in atopic dermatitis. Br J Dermatol 1996;135:25S-30S.
15. Cherill R, Gräber M, Hanifin JM, Omoto M, Thurston M, Tofte S: Eczema area and severity index (EASI) - A new tool to evaluate atopic dermatitis. Abstr Singapore 2000, June 1998.
16. Finlay AY: Measurement of disease activity and outcome in atopic dermatitis. Br J Dermatol 1996;135:509-515.
17. Herd RM, Tidman MJ, Ruta DA, Hunter JA: Measurements of quality of life in atopic dermatitis: Correlation and validation of two different methods. Br J Dermatol 1997;136: 502-507.
18. Wahlgren CF, Scheynius A, Hägermark Ö: Antipruritic effect of oral cyclosporin in atopic dermatitis. Acta Derm Venereol (Stockh) 1990; 70:323-329.
19. Sowden JM, Berth-Jones J, Ross JS, Motley RJ, Marks R, Finlay AY, Salek MS, Graham-Brown RA, Allen BR, Camp RD: Double-blind, controlled, crossover study of cyclosporin in adults with severe refractory atopic dermatitis. Lancet 1991;338:137-140.
20. Salek MS, Finlay AY, Luscombe DK, Allen BR, Perth-Jones J, Camp RDR, Graham-Brown RAC, Khan GK, Marks R, Motley RJ, Ross JS, Sowden JM: Cyclosporin greatly improves the quality of life of adults with severe atopic dermatitis: A randomized, double-blind, placebo-controlled trial. Br J Dermatol 1993;129:422-430.
21. Munro C, Levell N, Friedmann P, Shuster S: Low dose or intermittent cyclosporin maintains remission in atopic dermatitis (abstract). Br J Dermatol 1992;127(suppl 40):13-14.
22. Munro CS, Levell NJ, Shuster S, Friedmann P: Maintenance treatment with cyclosporin in atopic eczema. Br J Dermatol 1994;130:376-380.
23. Van Joost T, Heule F, Korstanje M, Van den Broek MJTB, Stenveld HJ, Van Vloten WA: Cyclosporin in atopic dermatitis: A multicentre placebo-controlled study. Br J Dermatol 1994; 130:634-640.
24. Granlund H, Erkko P, Sinisalo M, Reitamo S: Cyclosporin in atopic dermatitis: Time to relapse and effect of intermittent therapy. Br J Dermatol 1995;132:106-112.
25. Zonneveld IM, De Rie MA, Beljaards RC, Van der Rhee HJ, While J, Zeegelaar J, Bos JD: The long-term safety and efficacy of cyclosporin in severe refractory atopic dermatitis: A comparison of two dosage regimens. Br J Dermatol 1996;135(suppl 48):15-20.
26. Berth-Jones J, Graham-Brown RAC, Marks R, Camp RDR, English JS, Freeman K, Holden CA, Rogers SC, Ohiwiecki S, Friedman PS, Lewis-Jones MS, Archer CB, Adriaans B, Douglas WS, Allen BR: Long-term efficacy and safety of cyclosporin in severe adult atopic dermatitis. Br J Dermatol 1997;136:76-81.
27. Granlund H, Erkko P, Reinamo S: Long-term follow-up of eczema patients treated with cyclosporine. Acta Derm Venereol (Stockh) 1998;78:40-43.
28. Berth-Jones J, Finlay AY, Zaki I, Tan B, Goodyear H, Lewis-Jones S, Cork MJ, Bleehen SS, Salek MS, Allen BR, Smith S, Graham Brown RA: Cyclosporine in severe childhood atopic dermatitis: A multicenter study. J Am Acad Dermatol 1996;34:1016-1021.
29. Zaki I, Emerson R, Allen BR: Treatment of severe atopic dermatitis in childhood with cyclosporin. Br J Dermatol 1996;135(suppl 48): 21-24.
30. Harper JI: Short course versus continuous course therapy of cyclosporin (Neoral®) in severe childhood atopic dermatitis (abstract). Ann Dermatol Vénéréol 1998;125(suppl 1):64.
31. Zachariae H, Kragball K, Hansen HE, Marcussen N, Olsen S: Renal biopsy findings in long-term cyclosporin treatment of psoriasis. Br J Dermatol 1997;136:531-535.
32. Berth-Jones J, Voorhees JJ: Consensus conference on cyclosporin A microemulsion for psoriasis, June 1996. Br J Dermatol 1996;135: 775-777.
33. Rimer BK, Schildkraut J: Cancer screening; in DeVita VT, Hellman S, Rosenberg SA (eds): Cancer - Principles and Practice of Oncology, ed 5. Philadelphia, Lippincott-Raven Press, 1997, pp 619-631.